Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group.

Infants with cardiopulmonary disease develop severe illness from respiratory syncytial virus (RSV) infection. Safety, feasibility, and pharmacokinetics of intravenous gamma globulin (IVIG) to prevent RSV illness were studied in 23 high-risk infants in a phase I trial. IVIG with an RSV neutralizing a...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Groothuis, J R, Levin, M J, Rodriguez, W, Hall, C B, Long, C E, Kim, H W, Lauer, B A, Hemming, V G
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1991
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245192/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1718213/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.7.1469
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!